Predictors of Disease Progression in Early-Onset Alzheimer's Dementia: A Retrospective Cohort Study

J Am Med Dir Assoc. 2020 Nov;21(11):1735-1739. doi: 10.1016/j.jamda.2020.05.016. Epub 2020 Jul 4.

Abstract

Objectives: Early-onset Alzheimer's disease (EOAD), defined as onset of AD before the age of 65 years, is less common than the late-onset type, and little is known about the factors affecting disease progression. The aim of the study was to investigate factors influencing disease progression in people with EOAD.

Design: Retrospective cohort study.

Setting and participants: People with EOAD who were assessed and attended the specialist memory service at a university teaching hospital in a European setting, between 2000 and 2010.

Measures: Sociodemographic details and clinical and cognitive assessments at initial assessment were used as potential predictors of change in clinical status and outcome at final follow-up within the memory service.

Results: Of the 101 people diagnosed with EOAD during this period, 96 patients were followed up (53 women; aged 59 ± 4.9 years; mean follow-up 36.3 ± 29.12 months). Patients were classified as Stable (n = 25) if continued within the memory service or discharged to primary care, and those transferred to other specialist services (n = 66) for further inputs, institutional care (n = 4), or died (n = 1) were classified as Worseners (n = 71). Lower education (P = .008), lower Cambridge Cognition Examination scores (P = .049), and presence of family history of dementia [P = .012, χ2 (1) = 8.84] was associated with worse change in clinical status. Furthermore, cognitive deficits such as lower scores on comprehension, recent memory, and executive functions were found to predict a worse clinical outcome.

Conclusions and implications: Identification of predictors of faster disease progression has significant clinical benefit, allowing clinicians to estimate prognosis and plan patient care accordingly.

Keywords: Alzheimer's disease; disease progression; early onset; outcome.

MeSH terms

  • Age of Onset
  • Aged
  • Alzheimer Disease* / diagnosis
  • Alzheimer Disease* / epidemiology
  • Disease Progression
  • Female
  • Humans
  • Memory
  • Retrospective Studies